| Literature DB >> 34066071 |
Mengwan Li1,2, Ying Shen1,2, Tiejun Ling1,2, Chi-Tang Ho2,3, Daxiang Li1,2, Huimin Guo1,4, Zhongwen Xie1,2.
Abstract
Zijuan tea (Camellia sinensis var. assamica cv. Zijuan) is a unique purple tea. Recently, purple tea has drawn much attention for its special flavor and health benefits. However, the characteristic compounds of purple tea compared with green tea have not been reported yet. The present study employed a non-targeted metabolomics approach based on ultra-high performance liquid chromatography (UHPLC)-Orbitrap-tandem mass spectrometry (MS/MS) for comprehensive analysis of characteristic metabolites between Zijuan purple tea (ZJT) and Yunkang green tea (YKT). Partial least squares-discriminant analysis (PLS-DA) indicated that there are significant differences in chemical profiles between ZJT and YKT. A total of 66 major differential metabolites included catechins, proanthocyanins, flavonol and flavone glycosides, phenolic acids, amino acids and alkaloids were identified in ZJT. Among them, anthocyanins are the most characteristic metabolites. Nine glycosides of anthocyanins and six glycosides of proanthocyanins were found to be significantly higher in ZJT than that in YKT. Subsequently, pathway analysis revealed that ZJT might generate anthocyanins and proanthocyanins through the flavonol and flavone glycosides. Furthermore, quantitative analysis showed absolutely higher concentrations of total anthocyanins in ZJT, which correlated with the metabolomics results. This study presented the comprehensive chemical profiling and the characterized metabolites of ZJT. These results also provided chemical evidence for potential health functions of ZJT.Entities:
Keywords: UHPLC–Orbitrap–MS/MS; Yunkang green tea; Zijuan purple tea; anthocyanins; characteristic chemical compounds; metabolite profiling; proanthocyanins
Year: 2021 PMID: 34066071 PMCID: PMC8151513 DOI: 10.3390/foods10051070
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Multivariate statistical analysis of the differences in metabolites between Zijuan purple tea (ZJT) and Yunkang green tea (YKT). (A) Principal component analysis (PCA)-X score in positive ion mode (R2X = 0.73; Q2 = 0.47); (B) partial least squares-discriminant analysis (PLS-DA) score in positive ion mode (R2X = 0.519; R2Y = 0.996; Q2 = 0.972); (C) PLS-DA model validation in positive ion mode (R2 = 0.818; Q2 = −0.0476); (D) PCA-X score in negative ion mode (R2X = 0.638; Q2 = 0.506); (E) PLS-DA score in negative ion mode (R2X = 0.656; R2Y = 0.999; Q2 = 0.991); (F) PLS-DA model validation in negative ion mode (R2 = 0.626; Q2 = −0.226).
Differential metabolites in ZJT and YKT samples by metabolomics analysis based on ultra-high performance liquid chromatography combined with Orbitrap mass spectrometry (UHPLC-Orbitrap-MS/MS).
| Compound Name | RT (min) | Detected Mass | Theoretical Mass | Adduct | Formula | MS/MS Fragment | VIP | |Log2 FC| | FC | |
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Epiafzelechin 3- | 4.30 | 426.0945 | 426.0951 | [M-H2O-H]- | C22H18O9 | 169, 125 | 1.38 | 2.00 × 10−9 | 1.30 | 2.46 |
| Epicatechin 3- | 4.49 | 442.0925 | 442.0905 | [M-H2O-H]- | C22H18O10 | 123, 139, 153 | 1.37 | 3.00 × 10−8 | 1.97 | 3.91 |
| Catechin * | 4.60 | 290.0785 | 290.0790 | [M+H]+ | C15H14O6 | 95,97,109,123,125 | 1.23 | 2.00 × 10−4 | 0.83 | 1.78 |
| Epigallocatechin gallate * | 5.02 | 458.0831 | 458.0849 | [M+H]+ | C22H18O11 | 139, 151, 289 | 1.45 | 4.00 × 10−3 | 1.31 | 0.40 |
| Epigallocatechin 3-(3”-methylgallate) | 5.96 | 472.1006 | 472.1006 | [M-H]- | C23H20O11 | 139, 140, 167 | 1.38 | 4.00 × 10−9 | 6.06 | 66.66 |
| Epicatechin 3- | 7.32 | 456.1055 | 456.1056 | [M-H]- | C23H20O10 | 109, 124, 168, 183, 289 | 1.38 | 2.00 × 10−8 | 7.61 | 195.68 |
| Epicatechin * | 7.34 | 290.0793 | 290.0790 | [M-H]- | C15H14O6 | 123, 139, 147, 207 | 1.37 | 2.00 × 10−8 | 3.57 | 11.87 |
| Epigallocatechin 3- | 8.12 | 452.1109 | 452.1107 | [M-H]- | C24H20O9 | 196, 255 | 1.37 | 5.00 × 10−8 | 1.60 | 3.03 |
|
| ||||||||||
| Epigallocatechin-(4beta->8)-epicatechin 3- | 4.27 | 746.1481 | 746.1483 | [M+H]+ | C37H30O17 | 305, 443, 579 | 1.36 | 3.00 × 10−7 | 1.73 | 3.32 |
| Procyanidin B5 | 5.25 | 578.1430 | 578.1424 | [M-H2O-H]- | C30H26O12 | 289, 469 | 1.37 | 8.00 × 10−8 | 3.05 | 8.29 |
| 3- | 5.50 | 738.1771 | 738.1796 | [M+Na]+ | C36H34O17 | 195, 455, 723 | 1.31 | 8.00 × 10−6 | 9.93 | 976.56 |
| Prodelphinidin B | 6.01 | 610.1335 | 610.1323 | [M+H]+ | C30H26O14 | 309, 757 | 1.38 | 2.00 × 10−9 | 2.46 | 5.49 |
| Epigallocatechin 3- | 6.67 | 898.1590 | 898.1593 | [M+H]+ | C44H34O21 | 433, 741 | 1.32 | 5.00 × 10−6 | 1.39 | 2.62 |
| Epiafzelechin 3- | 7.41 | 882.1608 | 882.1643 | [M+H]+ | C44H34O20 | 271, 441, 591 | 1.25 | 8.00 × 10−5 | 1.53 | 2.89 |
|
| ||||||||||
| Myricetin | 3.65 | 318.0383 | 318.0376 | [M-H2O-H]- | C15H8O7 | 125, 169, 241 | 1.39 | 9.00 × 10−10 | 4.31 | 19.85 |
| Vitexin 2″- | 3.77 | 620.1727 | 620.1741 | [M-H2O-H]- | C29H32O15 | 339, 449, 493 | 1.16 | 9.00 × 10−4 | 0.69 | 1.61 |
| Kaempferol 3- | 4.05 | 418.0891 | 418.0900 | [M+H]+ | C20H18O10 | 211, 401 | 1.37 | 7.00 × 10−8 | 5.07 | 33.57 |
| Quercetin 3-galloylglucosyl-arabinofuranoside | 4.32 | 748.1520 | 748.1487 | [M-H]- | C33H32O20 | 229, 285 | 1.38 | 8.00 × 10−9 | 2.46 | 5.50 |
| Myricetin 3-rhamnoside-3′-glucoside | 4.95 | 626.1495 | 626.1483 | [M-H]- | C27H30O17 | 178, 316 | 1.05 | 5.00 × 10−3 | 0.72 | 1.64 |
| Isovitexin 2″- | 4.95 | 578.1621 | 578.1636 | [M+H]+ | C27H30O14 | 247, 291, 409, 427 | 1.24 | 1.00 × 10−4 | 2.67 | 6.36 |
| Kaempferol 3-glucoside | 5.27 | 448.1007 | 448.1006 | [M-H2O-H]- | C21H20O11 | 145, 301, 377 | 1.29 | 2.00 × 10−5 | 1.34 | 2.52 |
| Kaempferol 7,4′-dirhamnoside | 5.50 | 578.1629 | 578.1636 | [M-H]- | C27H30O14 | 245, 289 | 1.26 | 6.00 × 10−5 | 2.75 | 6.72 |
| Pelargonidin 3-rhamnoside 5-glucoside | 5.50 | 579.1722 | 579.1714 | [M-H]- | C27H31O14 | 154, 245, 289, 469 | 1.25 | 1.00 × 10−4 | 2.79 | 6.90 |
| Cyanidin 3-sambubioside | 5.63 | 581.1510 | 581.1506 | [M-H]- | C26H29O15 | 419, 435, 449, 458 | 1.28 | 3.00 × 10−5 | 0.99 | 1.99 |
| Quercetin 3-rutinoside-4′-glucoside | 5.90 | 772.2045 | 772.2062 | [M-H]- | C33H40O21 | 151, 255, 271, 301, 300 | 1.31 | 7.00 × 10−6 | 9.73 | 849.64 |
| Cyanidin 3-diglucoside 5-glucoside | 5.90 | 773.2145 | 773.2140 | [M-H]- | C33H41O21 | 277, 513 | 1.30 | 1.00 × 10−5 | 11.33 | 2579.02 |
| Kaempferol 3-(2″-hydroxypropionylglucoside)-4′-glucoside | 5.94 | 682.1734 | 682.1745 | [M-H2O-H]- | C30H34O18 | 213, 249, 327 | 1.36 | 3.00 × 10−7 | 4.87 | 29.33 |
| Delphinidin 3-(6- | 6.01 | 611.1379 | 611.1401 | [M+H]+ | C30H27O14 | 138, 331, 409 | 1.38 | 2.00 × 10−9 | 2.65 | 6.29 |
| Quercetagetin 7-methylether 6-glucoside | 6.04 | 494.1060 | 494.1060 | [M-H]- | C22H22O13 | 163, 319, 337 | 1.30 | 1.00 × 10−5 | 2.04 | 4.10 |
| Quercetin 3-arabinoside | 6.11 | 434.0853 | 434.0849 | [M-H]- | C20H18O11 | 343, 313 | 1.36 | 1.00 × 10−7 | 2.15 | 4.43 |
| Delphinidin-3- | 6.12 | 435.0933 | 435.0927 | [M-H]- | C20H19O11 | 165, 289, 341 | 1.26 | 8.00 × 10−5 | 2.11 | 4.33 |
| Quercetin 3-galactoside | 6.14 | 464.0944 | 464.0955 | [M+H]+ | C21H20O12 | 138, 303 | 1.08 | 3.00 × 10−3 | 0.91 | 1.88 |
| Cyanidin 3-(6″-acetylglucoside)-5-glucoside | 6.31 | 652.1641 | 652.1639 | [M-H2O-H]- | C29H32O17 | 207, 315, 515 | 1.08 | 3.00 × 10−3 | 0.63 | 1.55 |
| Pelargonidin 3-sophoroside 5-glucoside | 6.32 | 757.2184 | 757.2191 | [M+H]+ | C33H41O20 | 287, 433, 595 | 1.39 | 5.00 × 10−10 | 5.98 | 63.09 |
| Cyanidin 3- | 6.46 | 594.1373 | 594.1373 | [M+H]+ | C30H26O13 | 166, 273, 424, 442, 527 | 1.39 | 2.00 × 10−10 | 2.17 | 4.49 |
| Kaempferol 3-(6″-ferulylglucoside) | 6.51 | 624.1464 | 624.1479 | [M+H]+ | C31H28O14 | 317, 165, 203 | 1.33 | 2.00 × 10−6 | 8.49 | 360.45 |
| Pelargonidin 3-coumarylglucoside-5-acetylglucoside | 6.52 | 782.2061 | 782.2058 | [M-H2O-H]- | C38H38O18 | 457, 461, 337 | 1.31 | 1.00 × 10−5 | 3.73 | 13.26 |
| Kaempferol 3- | 6.53 | 798.2216 | 798.2219 | [M+H]+ | C35H42O21 | 519, 524 | 1.36 | 2.00 × 10−7 | 4.01 | 16.15 |
| Kaempferol 3-glucoside-7-xyloside | 6.83 | 580.1452 | 580.1428 | [M+H]+ | C26H28O15 | 271, 396 | 1.33 | 2.00 × 10−6 | 3.93 | 15.27 |
| Kaempferol 3-(4″-acetyl-6″- | 8.14 | 636.1456 | 636.1479 | [M-H2O-H]- | C29H32O16 | 313, 465, 483 | 1.36 | 2.00 × 10−7 | 3.16 | 8.93 |
| Quercetin 3,3′-dimethyl ether 4′-glucoside | 8.58 | 510.1369 | 510.1373 | [M-H2O-H]- | C23H26O13 | 285, 442, 599 | 1.18 | 5.00 × 10−4 | 1.04 | 2.05 |
| Kaempferol | 8.90 | 286.0465 | 286.0477 | [M+H]+ | C15H10O6 | 121, 165, 241 | 1.55 | 4.00 × 10−3 | 1.80 | 0.29 |
|
| ||||||||||
| Phenol | 0.74 | 94.0414 | 94.0419 | [M+H]+ | C6H6O | 62, 73, 82 | 1.23 | 4.00 × 10−3 | 1.24 | 0.42 |
| 5- | 1.51 | 354.0955 | 354.0951 | [M-H]+ | C16H18O9 | 103, 175 | 1.36 | 2.00 × 10−7 | 2.33 | 5.02 |
| Chlorogenic acid | 2.42 | 354.0933 | 354.0951 | [M+Na]+ | C16H18O9 | 93, 135, 173, 191 | 1.47 | 4.00 × 10−3 | 0.71 | 0.61 |
| Salicylic acid | 4.24 | 138.0309 | 138.0317 | [M+H]+ | C7H6O3 | 56, 65, 116, 139, 140 | 1.52 | 4.00 × 10−3 | 1.44 | 0.37 |
| 4-Hydroxybenzoic acid | 5.02 | 138.0312 | 138.0317 | [M+H]+ | C7H6O3 | 56, 111, 116, 139, 140 | 1.40 | 4.00 × 10−3 | 0.69 | 0.62 |
| 3- | 7.35 | 184.0376 | 184.0372 | [M-H]- | C8H8O5 | 124, 139, 168 | 1.33 | 3.00 × 10−6 | 0.97 | 1.97 |
| 3- | 7.54 | 338.1000 | 338.1002 | [M-H2O-H]- | C16H18O8 | 93, 119, 173, 191 | 1.15 | 1.00 × 10−3 | 1.31 | 2.48 |
| Shikimic acid | 9.49 | 174.0521 | 174.0528 | [M-H2O-H]- | C7H10O5 | 61, 67, 93, 173 | 1.33 | 4.00 × 10−3 | 0.68 | 0.62 |
|
| ||||||||||
| Lysine | 0.63 | 146.1050 | 146.1055 | [M+H]+ | C6H14N2O2 | 72, 84, 128, 130 | 1.36 | 4.00 × 10−3 | 1.01 | 0.50 |
| Alanine | 0.72 | 89.0472 | 89.0477 | [M+H]+ | C3H7NO2 | 68, 77 | 1.27 | 4.00 × 10−3 | 0.88 | 0.54 |
| Aspartic acid | 0.74 | 133.0371 | 133.0375 | [M+H]+ | C4H7NO4 | 74, 88, 102, 116 | 1.15 | 4.00 × 10−3 | 1.84 | 0.28 |
| Methionine | 1.04 | 149.0503 | 149.0510 | [M+H]+ | C5H11NO2S | 102, 131 | 1.23 | 4.00 × 10−3 | 1.37 | 0.39 |
| Valine | 1.05 | 117.0785 | 117.0790 | [M+H]+ | C5H11NO2 | 58, 59, 118, 119 | 1.32 | 4.00 × 10−3 | 1.04 | 0.49 |
| Isoleucine | 1.92 | 131.0939 | 131.0946 | [M+H]+ | C6H13NO2 | 69, 72, 86, 90 | 1.39 | 4.00 × 10−3 | 0.89 | 0.54 |
| Tyrosine | 2.76 | 181.1882 | 181.1885 | [M-H]- | C9H11NO3 | 91, 119, 123, 136, 165 | 1.37 | 7.00 × 10−8 | 3.57 | 11.84 |
| Cysteine | 5.63 | 121.1586 | 121.1582 | [M-H]- | C3H7NO2S | 74, 100, 98 | 1.22 | 2.00 × 10−4 | 0.90 | 1.87 |
|
| ||||||||||
| Adenine | 0.63 | 135.0556 | 135.0545 | [M-H]- | C5H5N5 | 119 | 1.28 | 4.00 × 10−3 | 0.84 | 0.56 |
| 2-Acetylpyrazine | 1.04 | 122.0475 | 122.0480 | [M+H]+ | C6H6N2O | 80, 95, 96, 123 | 1.28 | 4.00 × 10−3 | 1.91 | 0.27 |
| 3-Methylxanthine | 1.15 | 166.0487 | 166.0491 | [M+H]+ | C6H6N4O2 | 120 | 1.28 | 4.00 × 10−5 | 3.17 | 9.01 |
| Ellagic acid | 3.86 | 302.0048 | 302.0063 | [M+H]+ | C14H6O8 | 57, 275, 285, 303 | 1.20 | 4.00 × 10−3 | 1.71 | 0.31 |
| 2-Acetylpyrrole | 4.27 | 109.0526 | 109.0528 | [M+Hac-H]- | C6H7NO | 67, 83 | 1.29 | 4.00 × 10−3 | 1.42 | 0.37 |
| Theophylline | 6.27 | 180.0641 | 180.0647 | [M-H2O+H]- | C7H8N4O2 | 135, 146, 161, 164 | 1.50 | 4.00 × 10−3 | 0.62 | 0.65 |
| Aquifoliunine EII | 6.32 | 721.2591 | 721.2582 | [M+K]+ | C34H43NO16 | 231, 273, 411 | 1.39 | 2.00 × 10−10 | 4.82 | 28.31 |
| Caffeine * | 9.54 | 194.0800 | 194.0804 | [M-H2O-H]- | C8H10N4O2 | 85, 93 | 1.30 | 4.00 × 10−3 | 0.59 | 0.66 |
Note: Fold change (FC) is based on comparing the mass intensity of metabolites between ZJT and YKT; metabolite marked with * is confirmed by standards.
Figure 2Heat map representing metabolites levels in ZJT and YKT. Red and blue boxes represent values that were higher and lower than the mean value, respectively.
Figure 3Concentration of anthocyanin in ZJT and YKT (mg/g) (n = 3, mean ± standard error of the mean (SEM)), ### p < 0.001, compared to ZJT.
Figure 4Pathway analysis of ZJT and YKT. The y-axis (−log (p-value)) and x-axis represents the significance of the pathway and pathway impact between ZJT and YKT, respectively.
Figure 5Metabolic pathways of flavone and flavonol biosynthesis and amino acid biosynthesis in ZJT and YKT. Red (LgFC > 0) and blue (LgFC < 0) boxes represent values that were higher and lower than the mean value, respectively.